Cardiovascular Rounds

News, resources, and analysis from the Cardiovascular Roundtable

Filtered by: Service Lines Hide

The results are in: What's the current state of hybrid OR use?

Aaron Mauck September 28, 2016

As hospitals confront rising demand for minimally invasive procedures, interest in the hybrid OR has grown among CV administrators and clinical staff alike. The hybrid OR offers advantages over the traditional surgical suite, allowing practitioners to combine surgical and interventional approaches, which is why it's no surprise the AHA reports that 75% of CV surgeons expect to be working within a hybrid OR space by 2018.

Despite the attention the hybrid OR has received, it remains unclear how programs are planning their hybrid OR investments or utilizing their existing hybrid OR suites. That's why we recently asked you to help us better understand the current state of this technology. Here's what we found.

Read more »

Quick poll: What's the current state of your hybrid OR?

Aaron Mauck September 9, 2016

Here at the Cardiovascular Roundtable, we receive a lot of questions about how to plan for hybrid operating rooms. Given the investment considerations around this technology, getting a better understanding of how CV programs use their existing hybrid OR space or plan for future expansion is imperative. So we would like to put the question to you.

You can see real time results on how programs are planning for expansion by answering the following brief questions, and we will provide a full report of our findings in an upcoming post.

Read more »

Breaking: FDA approves TAVR in intermediate risk patients

by Marissa Schwartz August 22, 2016

TAVR indications have expanded dramatically, thanks to recent FDA approval of two devices in intermediate-risk patients. Read on to see our analysis of this newest TAVR update.

Read more »

How does your CABG staff mix compare?

Aaron Mauck August 19, 2016

We often get a lot of questions about how to appropriately staff procedures, so we recently asked you how you staff for CABG in your own programs. The results of our survey are now in, and we would like to share them with you.

Read more »

New AF quality guidelines help standardize a complicated field

by Marissa Schwartz August 3, 2016

Atrial fibrillation (AF) affects between 2.7 and 6.1 million U.S. adults, and its prevalence is expected to more than double by 2050. Despite its significant toll, efforts to standardize treatment guidelines and define quality metrics have been less intensive for AF than for many other CV conditions. So what’s an electrophysiologist to do?

Read more »

Breaking: CMS proposes mandatory bundling for CABG, AMI

Megan Tooley July 26, 2016

A shockwave hit the world of CV services on Monday, as CMS released a proposal for a new mandatory bundled payment model for CABG and AMI.

The proposed rule contains three new significant policies:

  • A mandatory episode payment model (EPM) for CABG and AMI (note they are also extending the existing bundled payment model for hip replacements to other hip surgeries)
  • A new payment model for cardiac rehab meant to increase utilization
  • A track that would enable physicians with significant participation in bundled payment models to qualify for the Advanced Alternative Payment model track in MACRA

Read more »

Want better CV care? Include pharmacists.

by Julie Bass July 6, 2016

We’ve reported on the benefits of including pharmacists in CV care teams in the past, and now new research is strengthening evidence to support involving pharmacists in CV patient care.

A new study in the Journal of the American College of Cardiology this month set out to evaluate the effectiveness of a community pharmacy-based intervention on CV risk. The results? CVD risk was reduced and patient outcomes improved in the intervention group. If you aren’t including pharmacists in your CV care teams yet, you’ll want to after reading more.

Read more »

How sex differences in atrial fibrillation can impact CV care

by Marissa Schwartz June 30, 2016

Sex-based differences in cardiovascular conditions are well known. Prevalence, presentation, and prognosis for men and women can vary significantly. However, a new analysis of the ORBIT-AF registry suggests that sex differences in atrial fibrillation (AF) morbidity and mortality may fall along counterintuitive lines, with women being at greater risk for adverse events than men, but experiencing lower overall mortality. This observation has important implications for how physicians treat AF patients.

Read more »

Comment Now

You must be logged in to comment

What Your Peers Are Saying

Rating: | Brian Maher | March 30, 2012